Loading clinical trials...
Loading clinical trials...
Phase II Study of PD-1 Blockade Alone or In Conjunction With the Dendritic Cell (DC)/Renal Cell Carcinoma (RCC) Fusion Cell Vaccination
Conditions
Interventions
CT-011
DC/RCC fusion vaccine
Locations
1
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Start Date
November 1, 2011
Primary Completion Date
July 1, 2016
Completion Date
July 1, 2016
Last Updated
February 8, 2017
NCT07485114
NCT06391099
NCT05738694
NCT07227402
NCT06349642
NCT07300241
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions